Anzeige
Mehr »
Login
Samstag, 23.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40FCP | ISIN: US81726A2096 | Ticker-Symbol:
NASDAQ
22.11.24
20:16 Uhr
2,180 US-Dollar
-0,010
-0,46 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SENTI BIOSCIENCES INC Chart 1 Jahr
5-Tage-Chart
SENTI BIOSCIENCES INC 5-Tage-Chart

Aktuelle News zur SENTI BIOSCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.11.Senti Biosciences GAAP EPS of -$6.313
12.11.Intel says it lowered stakes in Astera Labs, Joby Aviation, Senti Biosciences27
SENTI BIOSCIENCES Aktie jetzt für 0€ handeln
26.10.Senti Biosciences faces nasdaq delisting over audit rule3
25.10.Senti Biosciences, Inc. - 8-K, Current Report1
27.09.Senti Biosciences, Inc. - 8-K, Current Report9
03.09.Senti Biosciences, Inc.: Senti Bio to Participate in Upcoming Investor Conferences2
14.08.Senti Biosciences GAAP EPS of -$2.452
13.08.Senti Biosciences, Inc. - 10-Q, Quarterly Report1
13.08.Senti Biosciences, Inc. - 8-K, Current Report2
13.08.Senti Biosciences, Inc.: Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights232- Dose finding ongoing in Phase 1 clinical trial of SENTI-202 for the treatment of relapsed/refractory hematologic malignancies including AML - - Commencement of $8 million grant award from CIRM...
► Artikel lesen
05.08.Senti Biosciences, Inc.: Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-2024
16.07.Senti Biosciences to effect 1-for-10 reverse stock split for Nasdaq compliance3
16.07.Senti Biosciences, Inc.: Senti Bio Announces Reverse Stock Split114SOUTH SAN FRANCISCO, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) ("Senti Bio"), a biotechnology company developing next-generation cell and gene therapies using...
► Artikel lesen
12.07.Senti Biosciences, Inc. - 8-K, Current Report4
02.07.Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks49
01.07.Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening?11
01.07.Senti Biosciences, Inc.: Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy10
25.06.Why Is Senti Biosciences (SNTI) Stock Up 32% Today?4
13.05.Senti Biosciences, Inc.: Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia142- SENTI-202 is a potential first-in-class Logic Gated off-the-shelf CAR-NK cell therapy - - Initial clinical efficacy data expected by year-end 2024 and durability data expected in 2025 - SOUTH SAN...
► Artikel lesen
09.05.Senti Biosciences, Inc.: Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights795- First patient dosing of SENTI-202, a first-in-class logic-gated treatment for acute myeloid leukemia ("AML"), on track for the second quarter of 2024 - SOUTH SAN FRANCISCO, Calif., May 09, 2024...
► Artikel lesen
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1